Literature DB >> 23293512

Iatrogenic retinal breaks during 20-gauge vitrectomy for proliferative diabetic retinopathy.

Yumi Kamura1, Yukihiro Sato, Yuzou Deguchi, Fumihiko Yagi.   

Abstract

BACKGROUND: We classified iatrogenic retinal break formation during 20-gauge pars plana vitrectomy for proliferative diabetic retinopathy into three types according to the mechanism of development, and evaluated the association of each type with postoperative complications. This is the largest series of such patients published to date.
METHODS: This was a retrospective comparative study of 760 eyes from 609 cases who underwent primary 20-gauge vitrectomy for proliferative diabetic retinopathy and were followed-up for at least 6 months after surgery. Postoperatively, the eyes were classified as having vitreous hemorrhage only (group 1), fibrovascular membrane without traction retinal detachment (group 2), or fibrovascular membrane with traction retinal detachment (group 3).
RESULTS: The overall incidence of iatrogenic retinal breaks was 29%. Fibrovascular membrane dissection was associated with retinal break formation in 50 of the eyes in group 3, an incidence which was significantly higher than that in group 2 (P < 0.001). Posterior vitreous detachment creation and peripheral vitreous shaving were associated with retinal break formation in 8% of eyes overall, and oral dialysis occurred in 2%. Postoperatively, vitreous hemorrhage requiring washout, neovascular glaucoma, recurrent retinal detachments, and fibrovascular proliferation at the sclerotomy sites occurred in 4%, 4%, 3%, and 1%, respectively, of all eyes. Outcomes of eyes with these postoperative complications, other than vitreous hemorrhage, were poor. Multiple regression analysis revealed retinal break formation during fibrovascular membrane dissection to be significantly related to postoperative vitreous hemorrhage (P = 0.019), recurrent retinal detachments (P < 0.001), and neovascular glaucoma (P = 0.048). Oral dialysis was also significantly related to postoperative vitreous hemorrhage (P = 0.001).
CONCLUSION: Iatrogenic retinal break formation during fibrovascular membrane dissection was more likely to be the cause of poor outcomes than peripheral retinal breaks or oral dialysis.

Entities:  

Keywords:  20-gauge vitrectomy; iatrogenic retinal breaks; postoperative complications; proliferative diabetic retinopathy

Year:  2012        PMID: 23293512      PMCID: PMC3534296          DOI: 10.2147/OPTH.S38784

Source DB:  PubMed          Journal:  Clin Ophthalmol        ISSN: 1177-5467


Introduction

Vitreous surgery for proliferative diabetic retinopathy has been reported to be closely associated with severe intraoperative and postoperative complications.1 Iatrogenic breaks develop via different mechanisms, such as oral dialysis and during proliferative fibrovascular membrane dissection.2 To our knowledge, there has been only one previous study in which iatrogenic retinal breaks were classified according to mechanisms of development.2 In that study, breaks were divided into two groups, ie, posterior breaks and peripheral breaks, to allow incidence comparisons between 20-gauge and 23-gauge vitrectomy for proliferative diabetic retinopathy. In our study, iatrogenic breaks were classified into three types, ie, breaks occurring during fibrovascular membrane dissection, those occurring during the induction of posterior vitreous detachment or peripheral vitreous dissection, and oral dialysis related to the sclerotomy sites. Their incidences and associations with major postoperative complications were evaluated in the largest published series to date of patients undergoing 20-gauge vitrectomy for proliferative diabetic retinopathy. These evaluations may provide basic data allowing comparison between 20-gauge vitrectomy and micro-incision vitreous surgery for proliferative diabetic retinopathy.

Materials and methods

The subjects consisted of 609 consecutive patients (760 eyes) who underwent their first operation for proliferative diabetic retinopathy between August 2001 and September 2003 at Nihon University Itabashi Hospital and between October 2003 and March 2008 at Sakura Medical Center Toho University Hospital. All were followed up for at least 6 months after their surgery. There were 385 males and 224 females of mean age 57.3 ± 11.4 (range 24–84) years. Vitreous surgery was performed using a 20-gauge three-port vitrectomy system. When there was no posterior vitreous detachment, it was induced. Proliferative membrane dissection using vertical or horizontal scissors and intraocular photocoagulation were performed, and intraocular tamponade was added when necessary. In phakic patients aged ≥ 50 years, cataract surgery was simultaneously performed. The operations were performed by 15 surgeons. Patients with neovascular glaucoma before surgery, those who underwent surgery to treat macular edema or to remove submacular hard exudates, and those with pre-existing retinal breaks including combined traction and rhegmatogenous retinal detachment were excluded. No patients were treated with bevacizumab (antivascular endothelial growth factor) either preoperatively or postoperatively. The subjects were classified postoperatively according to their disease type into three groups, ie, group 1 with vitreous hemorrhage only, group 2 with fibrovascular membranes requiring treatment without traction retinal detachment, and group 3 with fibrovascular membrane and traction retinal detachments. Iatrogenic breaks were classified into breaks occurring during fibrovascular membrane dissection (breaks during membrane dissection), breaks occurring during the induction of posterior vitreous detachment or peripheral vitreous dissection (peripheral breaks), and oral dialysis related to the sclerotomy sites. The postoperative complications evaluated were vitreous rebleeding requiring washout on reoperation (rebleeding), neovascularization at the sclerotomy site, retinal detachment due to reproliferation with or without retinal breaks, and neovascular glaucoma. This retrospective study was performed using medical records. Visual acuities were measured using a standard Japanese decimal visual acuity chart.

Statistical analysis

The χ2 test, mxn χ2 test, Fisher’s exact probability test, logistic regression analysis, and multiple comparisons with the Bonferroni method were used to perform the statistical analysis. P < 0.05 was regarded as being statistically significant. StatView 5.0 (SAS Institute Inc, Cary, NC, USA) was the statistical analysis software package used.

Results

Patients

Group 1 consisted of 239 patients (259 eyes), group 2 consisted of 286 patients (318 eyes), and group 3 of 161 patients (183 eyes). The mean ages of the patient were 60.0 ± 10.9, 56.2 ± 11.0, and 53.6 ± 12.0 years, respectively.

Incidence of iatrogenic breaks

All cases

Iatrogenic breaks occurred in 28.5% of all 760 eyes. Breaks during membrane dissection developed in 31.5% of eyes in groups 2 and 3 after membrane dissection. Peripheral breaks occurred in 7.5% and oral dialysis in 2.1% of all eyes.

According to group

Iatrogenic breaks occurred in 8.9%, 29.2%, and 62.8% of groups 1, 2, and 3, respectively (see Table 1). Breaks during membrane dissection were significantly more common in group 3 than in group 2 (P < 0.001, χ2 test). Incidences of peripheral breaks and oral dialysis did not differ significantly among the three groups (P = 0.359 and P = 0.087, respectively, mxn χ2 test).
Table 1

Incidence of each type of iatrogenic break

Iatrogenic breakGroup 1 (n = 259)Group 2 (n = 318)Group 3 (n = 183)P-value
During membrane dissectionNo dissection67 (21.0)91 (49.7)<0.001*
Peripheral21 (8.1)19 (6.0)17 (9.3)0.359
Oral dialysis2 (0.8)7 (2.2)7 (3.8)0.087

Notes: Group 1, vitreous hemorrhage only; group 2, fibrovascular membranes requiring treatment without traction retinal detachment; group 3, fibrovascular membrane with traction retinal detachments. Eyes (%). Some eyes showed multiple types of breaks.

mxn χ2 test;

χ2 test.

Postoperative complications

Evaluation of postoperative complications in all 760 eyes showed rebleeding in 3.6%, neovascularization at the sclerotomy site in 1.3%, retinal detachment due to reproliferation in 2.8%, and neovascular glaucoma in 3.9%. The incidence of rebleeding and that of neovascular glaucoma were higher in group 3 than in group 1 (P = 0.013 and P = 0.008, respectively, Bonferroni method; Table 2). Furthermore, the incidence of neovascularization at the sclerotomy site and that of retinal detachment due to reproliferation was higher in group 3 than in group 2 (P = 0.007 and P = 0.001, respectively, Bonferroni method, χ2 test).
Table 2

Postoperative complications

Group 1 (n = 259)Group 2 (n = 318)Group 3 (n = 183)P-value
Vitreous rebleeding5 (1.9)10 (3.1)12 (6.6)0.03
Neovascularization at the sclerotomy site3 (1.2)1 (0.3)6 (3.3)0.019
Retinal detachment due to reproliferation0 (0)6 (1.9)15 (8.2)<0.001*
Neovascular glaucoma6 (2.3)10 (3.1)14 (7.7)0.011

Notes: Eyes (%). Some eyes showed multiple types of breaks.

mxn χ2 test;

χ2 test.

Associations between visual outcomes after rebleeding and neovascularization at sclerotomy site

Vitreous rebleeding was observed in 27 eyes, ie, 10 eyes with and 17 eyes without neovascularization at the sclerotomy site. Final visual acuity was <0.1 in all 10 eyes showing neovascularization at the sclerotomy site, and in 41.2% of the 17 eyes without this complication. The final visual acuity was poorer in the presence of neovascularization at the sclerotomy site (P = 0.002, Fisher’s exact probability test). Neovascular glaucoma developed in 80.0% of the 10 eyes showing neovascularization at the sclerotomy site and 35.3% of the 17 eyes without this complication, being significantly more frequent in the presence of neovascularization (P = 0.031, Fisher’s exact probability test).

Associations between visual outcomes after retinal detachment due to reproliferation and neovascular glaucoma

Retinal detachment due to reproliferation occurred in 21 eyes. Reoperation for retinal detachment due to reproliferation was performed 1–3 (mean 1.4) times, and retinal reattachment was achieved in only 38% of these eyes. Final visual acuity was <0.1 in 25% of the eight eyes showing retinal reattachment, but was <0.1 in all 13 eyes without retinal reattachment, with poorer visual acuity in the latter (P < 0.001, Fisher’s exact probability test). None of the eight eyes showing retinal reattachment developed neovascular glaucoma, but this complication did occur in 38.5% of the 13 eyes without retinal reattachment. However, the incidences did not differ significantly between the two groups (P = 0.063, Fisher’s exact probability test).

Associations between iatrogenic breaks and postoperative complications

Associations between iatrogenic breaks and postoperative complications were evaluated by logistic regression analysis. Breaks during membrane dissection were significantly associated with vitreous rebleeding (P = 0.019), retinal detachment due to reproliferation (P < 0.001), and neovascular glaucoma (P = 0.048; Table 3). Peripheral breaks were not associated with postoperative complications, while oral dialysis was associated with rebleeding (P = 0.001).
Table 3

Iatrogenic breaks and postoperative complications

VHNVRDNVG
Breaks during membrane dissection
 OR2.6 (1.2–5.7)1.7 (0.42–7.3)8.0 (3.3–19.4)2.2 (1.0–4.8)
P-value0.0190.444<0.0010.048
Peripheral breaks
 OR1.3 (0.29–5.7)3.9 (0.77–20.1)1.0 (0.138.1)1.1 (0.25–4.8)
P-value0.7370.1000.9860.910
Oral dialysis
 OR8.0 (2.3–27.5)5.7 (0.64–50.7)3.0 (0.59–15.0)3.0 (0.64–14.4)
P-value0.0010.2000.1880.162

Abbreviations: VH, vitreous rebleeding; NV, neovascularization at sclerotomy site; RD, retinal detachment due to reproliferation; NVG, neovascular glaucoma; OR, odds ratio (95% confidence interval).

Discussion

Vitreous surgery for proliferative diabetic retinopathy is associated with severe intraoperative and postoperative complications, which might cause worsening of visual outcomes.1 Iatrogenic retinal breaks and intraocular bleeding are major intraoperative complications.1 However, iatrogenic breaks include breaks occurring by different mechanisms, such as breaks at the posterior pole during fibrovascular membrane dissection, those in the peripheral retina during posterior vitreous detachment induction or thorough dissection of the peripheral vitreous, and oral dialysis associated with instrument insertion and removal, and their influences on outcomes would presumably differ. To our knowledge, there has been only one previous study in which iatrogenic retinal breaks were classified according to the mechanisms of development.2 However, the relationships between iatrogenic breaks and postoperative complications were not evaluated. Herein, we clarified the associations between iatrogenic breaks and major postoperative complications in the largest series of patients undergoing 20-gauge vitrectomy for proliferative diabetic retinopathy published to date. These evaluations may provide basic data allowing comparison between 20-gauge vitrectomy and microincision vitreous surgery for proliferative diabetic retinopathy. Among postoperative complications, vitreous rebleeding consistently develops at a predictable rate after vitreous surgery for proliferative diabetic retinopathy despite its minimal influences on visual outcomes.1 In contrast, neovascularization at the sclerotomy site, retinal detachment due to reproliferation, and neovascular glaucoma are considered to carry poor prognoses.1,3–5 In this study, certain iatrogenic breaks occurred in about 30% of all cases. Studies in more than 100 eyes have shown the incidence of iatrogenic breaks in 20-gauge surgery to range from 33% to 41%.3,6,7 Breaks developed in about 30% of our cases during fibrovascular membrane dissection. The incidence was significantly higher in those with traction retinal detachment. This difference might be attributable to traction retinal detachment inducing atrophy and fragility of the detached retina, thereby allowing the development of iatrogenic retinal breaks. The incidence of peripheral breaks developing during induction of posterior vitreous detachment or peripheral vitreous dissection, and that of oral dialysis related to the sclerotomy sites, did not differ significantly among the three groups. The incidence of peripheral breaks during the induction of posterior vitreous detachment or peripheral vitreous dissection is reportedly 6%,2 while those with oral dialysis have been shown to be 8%2 and 6%.8 Concerning postoperative complications, the incidence of each complication was highest in group 3, and the incidences of retinal detachment due to reproliferation and neovascular glaucoma were about 8% each. The incidence rates of each of these complications were similar to those obtained by Oda et al,3 who reported the highest incidence of postoperative complications in the traction retinal detachment group and that incidences of reproliferation and neovascular glaucoma each exceeded 10%. Therefore, cases with fibrovascular membranes should be closely followed up. If progressive membrane contraction likely to cause traction retinal detachment is detected, surgical intervention should be considered. Evaluating the association between iatrogenic breaks and postoperative complications may provide useful information for the management of patients who have already developed this detachment. Oda et al3 evaluated the association between iatrogenic breaks and postoperative complications, and the final visual acuity was <0.1 in 30% of cases developing iatrogenic retinal breaks, and the odds ratio as a risk factor for final visual acuity < 0.1 was 1.9. Yorston et al7 reported iatrogenic breaks to be a risk factor for worsening of postoperative visual acuity. However, in their study, the types of iatrogenic breaks were not evaluated. In the present study, retinal breaks during fibrovascular membrane dissection were significantly associated with postoperative rebleeding, retinal detachment due to reproliferation, and neovascular glaucoma. Furthermore, there was a significant association between oral dialysis and rebleeding. Therefore, if the incidences of iatrogenic breaks during membrane dissection and oral dialysis can be lowered, the incidences of these postoperative complications can likely be reduced as well. Despite providing basic data on iatrogenic retinal breaks during 20-gauge vitrectomy for proliferative diabetic retinopathy in the largest published patient series to date, this study is limited by being retrospective and non-randomized. A prospective, randomized clinical trial is needed for comparison between 20-gauge vitrectomy and micro-incision vitreous surgery for proliferative diabetic retinopathy.
  6 in total

1.  [Vitrectomy for proliferative diabetic retinopathy].

Authors:  Akiko Higuchi; Haruhiko Yamada; Emi Kawai; Yoshito Fujiseki; Mitsumasa Wada; Katsuji Kiuchi; Yoshiko Uchida; Keizo Minamino; Miyo Matsumura
Journal:  Nippon Ganka Gakkai Zasshi       Date:  2005-03

2.  [Recent outcomes of vitreous surgery for diabetic retinopathy].

Authors:  Hitoshi Oda; Kimihito Konno; Kyoko Mitsui; Etsuko Kawamata; Tomoyuki Hiraoka; Daijiro Miki
Journal:  Nippon Ganka Gakkai Zasshi       Date:  2005-09

3.  Complications of vitreous surgery for diabetic retinopathy. I. Intraoperative complications.

Authors:  R T Oyakawa; A P Schachat; R G Michels; T A Rice
Journal:  Ophthalmology       Date:  1983-05       Impact factor: 12.079

4.  Neovascularization from scleral wound as cause of vitreous rebleeding after vitrectomy for proliferative diabetic retinopathy.

Authors:  H Sawa; T Ikeda; Y Matsumoto; A Niiya; S Kinoshita
Journal:  Jpn J Ophthalmol       Date:  2000 Mar-Apr       Impact factor: 2.447

5.  Predictive clinical features and outcomes of vitrectomy for proliferative diabetic retinopathy.

Authors:  D Yorston; L Wickham; S Benson; C Bunce; R Sheard; D Charteris
Journal:  Br J Ophthalmol       Date:  2008-03       Impact factor: 4.638

6.  Comparison of retinal breaks observed during 23 gauge transconjunctival vitrectomy versus conventional 20 gauge surgery for proliferative diabetic retinopathy.

Authors:  Sharif A Issa; Alan Connor; Maged Habib; David Hw Steel
Journal:  Clin Ophthalmol       Date:  2011-01-20
  6 in total
  8 in total

Review 1.  Current management of vitreous hemorrhage due to proliferative diabetic retinopathy.

Authors:  Jaafar El Annan; Petros E Carvounis
Journal:  Int Ophthalmol Clin       Date:  2014

Review 2.  Surgical management of diabetic retinopathy.

Authors:  Vishali Gupta; J Fernando Arevalo
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Oct-Dec

3.  Segmentation and removal of fibrovascular membranes with high-speed 23 G transconjunctival sutureless vitrectomy, in severe proliferative diabetic retinopathy.

Authors:  Erkan Celik; Ozkan Sever; Fatih Horozoglu; Ates Yanyalı
Journal:  Clin Ophthalmol       Date:  2016-05-17

4.  Predictors and Outcomes of Vitrectomy and Silicone Oil Injection in Advanced Diabetic Retinopathy.

Authors:  Alireza Ramezani; Hamid Ahmadieh; Amin Rozegar; Masoud Soheilian; Morteza Entezari; Siamak Moradian; Mohammad H Dehghan; Homayoun Nikkhah; Mehdi Yaseri
Journal:  Korean J Ophthalmol       Date:  2017-05-12

5.  Twenty-seven-gauge vitrectomy for combined tractional and rhegmatogenous retinal detachment involving the macula associated with proliferative diabetic retinopathy.

Authors:  Yousef J Cruz-Iñigo; María H Berrocal
Journal:  Int J Retina Vitreous       Date:  2017-10-09

6.  Visual outcomes and complications following one-way air-fluid exchange technique for vitreous hemorrhage post vitrectomy in proliferative diabetic retinopathy patients.

Authors:  Baojie Hou; Yifei Huang; Qun Wang; Jie Zhao; Qing Xu; Cui Han
Journal:  BMC Ophthalmol       Date:  2021-03-09       Impact factor: 2.209

7.  Pars plana vitrectomy in vitreous hemorrhage with or without Intravitreal Bevacizumab a comparative overview.

Authors:  Syed Muhammad Faisal; Muhammad Ali Tahir; Alyscia Miriam Cheema; Muhammad Ijaz Anjum
Journal:  Pak J Med Sci       Date:  2018 Jan-Feb       Impact factor: 1.088

Review 8.  Current management of diabetic tractional retinal detachments.

Authors:  Michael W Stewart; David J Browning; Maurice B Landers
Journal:  Indian J Ophthalmol       Date:  2018-12       Impact factor: 1.848

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.